Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-18 5:15 pm Purchase | 2021-02-08 | 13D | Landos Biopharma, Inc. LABP | Perceptive Advisors LLC | 1,796,084 45.900% | 1,796,084 (New Position) | Filing History |
| 2021-02-16 8:57 pm Purchase | 2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 3,410,412 13.200% | 3,410,412 (New Position) | Filing History |
| 2021-02-16 4:00 pm Purchase | 2020-12-31 | 13G | Neptune Wellness Solutions Inc. NEPT | Perceptive Advisors LLC | 15,868 17.200% | 2,698 (+20.49%) | Filing History |
| 2021-02-16 3:57 pm Sale | 2020-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | Perceptive Advisors LLC | 2,577,043 4.300% | -676,880 (-20.80%) | Filing History |
| 2021-02-16 3:54 pm Purchase | 2020-12-31 | 13G | Agile Therapeutics, Inc. AGRX | Perceptive Advisors LLC | 7,960 18.200% | 2,000 (+33.56%) | Filing History |
| 2021-02-16 3:50 pm Purchase | 2020-12-31 | 13G | Kadmon Holdings, Inc. KDMN | Perceptive Advisors LLC | 16,240,747 9.400% | 1,075,000 (+7.09%) | Filing History |
| 2021-02-16 3:50 pm Purchase | 2020-12-31 | 13G | SC Health Corporation SCPE | Perceptive Advisors LLC | 1,000,000 5.800% | 1,000,000 (New Position) | Filing History |
| 2021-02-16 3:48 pm Purchase | 2020-12-31 | 13G | C4 Therapeutics, Inc. CCCC | Perceptive Advisors LLC | 3,158,566 7.300% | 3,158,566 (New Position) | Filing History |
| 2021-02-16 3:47 pm Sale | 2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 0 0.000% | -3,410,412 (Position Closed) | Filing History |
| 2021-02-16 3:46 pm Purchase | 2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Perceptive Advisors LLC | 1,296,416 6.400% | 1,296,416 (New Position) | Filing History |
| 2021-02-16 3:46 pm Purchase | 2020-12-31 | 13G | Oncorus, Inc. ONCR | Perceptive Advisors LLC | 1,989,987 7.700% | 1,989,987 (New Position) | Filing History |
| 2021-02-16 3:46 pm Purchase | 2020-12-31 | 13G | Outset Medical, Inc. OM | Perceptive Advisors LLC | 189,855 6.700% | 189,855 (New Position) | Filing History |
| 2021-02-16 3:45 pm Purchase | 2020-12-31 | 13G | Rocket Pharmaceuticals, Inc. RCKT | Perceptive Advisors LLC | 3,396,867 5.600% | 3,396,867 (New Position) | Filing History |
| 2021-02-16 3:45 pm Purchase | 2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA | Perceptive Advisors LLC | 1,500,000 10.700% | 1,500,000 (New Position) | Filing History |
| 2021-02-16 3:44 pm Unchanged | 2020-12-31 | 13G | MEI Pharma, Inc. MEIP | Perceptive Advisors LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-02-16 3:42 pm Purchase | 2020-12-31 | 13G | Leap Therapeutics, Inc. LPTX | Perceptive Advisors LLC | 847,650 14.200% | 175,000 (+26.02%) | Filing History |
| 2021-02-16 3:41 pm Sale | 2020-12-31 | 13G | Molecular Templates, Inc. MTEM | Perceptive Advisors LLC | 40,121 1.200% | -170,821 (-80.98%) | Filing History |
| 2021-02-16 3:40 pm Purchase | 2020-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | Perceptive Advisors LLC | 2,058,068 6.000% | 336,346 (+19.54%) | Filing History |
| 2021-02-16 3:39 pm Purchase | 2020-12-31 | 13G | VYNE Therapeutics Inc. VYNE | Perceptive Advisors LLC | 1,505,323 14.300% | 1,505,323 (New Position) | Filing History |
| 2021-02-16 3:38 pm Sale | 2020-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA | Perceptive Advisors LLC | 0 0.000% | -1,141,484 (Position Closed) | Filing History |